Free Trial

Chill Brands Group (CHLL) Competitors

Chill Brands Group logo

CHLL vs. PXS, MXC, RGT, CEL, N4P, HELD, HLN, HIK, HCM, and INDV

Should you be buying Chill Brands Group stock or one of its competitors? The main competitors of Chill Brands Group include Provexis (PXS), Argent BioPharma (MXC), Argent BioPharma (RGT), Celadon Pharmaceuticals (CEL), N4 Pharma (N4P), Hellenic Dynamics (HELD), Haleon (HLN), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), and Indivior (INDV). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Chill Brands Group vs. Its Competitors

Provexis (LON:PXS) and Chill Brands Group (LON:CHLL) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment.

In the previous week, Provexis had 1 more articles in the media than Chill Brands Group. MarketBeat recorded 1 mentions for Provexis and 0 mentions for Chill Brands Group. Chill Brands Group's average media sentiment score of 0.00 beat Provexis' score of -0.71 indicating that Chill Brands Group is being referred to more favorably in the news media.

Company Overall Sentiment
Provexis Negative
Chill Brands Group Neutral

Provexis has higher revenue and earnings than Chill Brands Group. Provexis is trading at a lower price-to-earnings ratio than Chill Brands Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Provexis£1.20M12.07-£619.15K-£0.00-2,058.33
Chill Brands Group£305.70K0.00-£3.64M-£0.01N/A

Chill Brands Group has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Provexis' return on equity of -68.68% beat Chill Brands Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Provexis-73.10% -68.68% -56.14%
Chill Brands Group N/A -2,802.21%-44.64%

7.9% of Provexis shares are owned by institutional investors. Comparatively, 1.5% of Chill Brands Group shares are owned by institutional investors. 11.8% of Provexis shares are owned by insiders. Comparatively, 10.3% of Chill Brands Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Provexis has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Comparatively, Chill Brands Group has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500.

Summary

Provexis beats Chill Brands Group on 8 of the 12 factors compared between the two stocks.

Get Chill Brands Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHLL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHLL vs. The Competition

MetricChill Brands GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£8.11M£1.74B£6.12B£2.59B
Dividend YieldN/A2.95%5.65%5.30%
P/E Ratio-242.62116.3786.964,424.90
Price / SalesN/A1,568.89605.8899,677.99
Price / Cash11.5010.3737.9027.90
Price / BookN/A11.4912.558.04
Net Income-£3.64M£20.70B£3.31B£5.89B
7 Day Performance-1.44%4.45%4.28%4.35%
1 Month Performance-8.42%4.25%6.90%6.26%
1 Year PerformanceN/A9.68%70.54%143.90%

Chill Brands Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHLL
Chill Brands Group
N/AN/AN/AN/A£8.11M£305.70K-242.627Gap Down
PXS
Provexis
N/AGBX 0.62
flat
N/A+2.9%£14.49M£1.20M-2,058.334
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32M-13.255Gap Up
RGT
Argent BioPharma
N/AN/AN/AN/A£8.31MN/A-0.65N/AGap Down
High Trading Volume
CEL
Celadon Pharmaceuticals
N/AGBX 13.40
flat
N/AN/A£8.22M£123.38K-1.682,780
N4P
N4 Pharma
N/AGBX 0.64
+2.9%
N/A+2.8%£5.35M£7.28K-207.425Gap Down
HELD
Hellenic Dynamics
N/AGBX 0.01
flat
N/AN/A£14KN/A0.00N/A
HLN
Haleon
2.2929 of 5 stars
GBX 329.70
-1.0%
GBX 436.67
+32.4%
-14.4%£29.51B£11.02B1,974.2525,408
HIK
Hikma Pharmaceuticals
3.8296 of 5 stars
GBX 1,833
+2.1%
GBX 2,627.50
+43.3%
-3.1%£4.06B£3.22B1,097.609,100
HCM
HUTCHMED
N/AGBX 236
+2.2%
N/A-21.9%£2.03B£602.20M445.281,760
INDV
Indivior
2.0446 of 5 stars
GBX 1,238
+1.6%
GBX 1,800
+45.4%
+57.8%£1.93B£1.40B-1,026.481,000News Coverage
Gap Up
High Trading Volume

Related Companies and Tools


This page (LON:CHLL) was last updated on 10/5/2025 by MarketBeat.com Staff
From Our Partners